Industry News
Research, Science & Manufacturer Updates
Washington Report Articles
The Medicare Rights Center has launched Medicare Interactive (MI), a free online resource with hundreds of answers to Medicare questions.
The Centers for Medicare and Medicaid Services published its annual Notice of Benefit and Payment Parameters, which governs participation in the Affordable Care Act health insurance marketplaces for 2017.
The Centers for Medicare and Medicaid Services has published several policies on biosimilars reimbursement.
In response to concerns by providers about the ICD-9 to ICD-10 coding system, the Centers for Medicare and Medicaid Services says it will reimburse for incorrectly coded claims for one year past the Oct. 1, 2015, deadline.
The Centers for Medicare and Medicaid Services has created an interactive online dashboard to allow the public and policymakers to explore the financial burden that high-expense drugs place on the Medicare program and the nation’s seniors.
The U.S. Department of Health and Human Services (HHS) has announced additional funding under the Affordable Care Act (ACA) and other programs. Under the ACA, nearly $500 million is being awarded to health centers nationwide to provide primary care services to those who need them most.
Doctors who care for tens of millions of chronically ill Medicare patients are failing to take advantage of federal dollars intended to improve care and reduce hospital readmissions and overall costs, according to the Centers for Medicare and Medicaid Services (CMS).
Healthcare.gov, the main entry point for people seeking insurance in 38 states served by the federal exchange, features three new window-shopping features.
To make the U.S.healthcare system more accountable, the federal government continues to release Medicare claims and payment information.
The U.S. Senate Appropriations Committee approved the fiscal year 2016 appropriations bill to fund the U.S. Food and Drug Administration but at levels far below what President Obama requested.
President Obama signed a bill into law that will compensate patients for participating in clinical studies of rare diseases.